Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04227353
Other study ID # NHS001653
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 30, 2021
Est. completion date September 30, 2022

Study information

Verified date October 2022
Source University of Manchester
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Trial Design: This is a feasibility randomised controlled trial. Aim: The study aims to test the Healthy Eating and Active Lifestyle After Bowel Cancer - HEAL ABC intervention and HEAL ABC resources for feasibility and will inform a future definitive randomised controlled trial (RCT). Objectives: 1. Is it practical to run HEAL ABC study as a definitive randomised controlled trial? 2. Adherence to intervention, motivations, barriers and facilitators of CRC survivors to follow HEAL ABC. Study Population: Colorectal cancer survivors who completed surgery and/or active treatment. Intervention: The intervention group will use HEAL ABC resource with supportive telephone calls every two weeks during the intervention period and once a month during the follow up period. Control: Participants follow standard care recommendations. Timing and duration: 3 months intervention with 6 months follow up period


Description:

Background: Investigators were awarded a grant to develop a lifestyle resource called HEAL ABC - the Healthy Eating and Active Lifestyle After Bowel Cancer. This resource is based on prevention guidelines of World Cancer Research Fund and American Institute of Cancer Research. The resource was developed in cooperation with a psychologist and so has incorporated behaviour change theory. Investigators organised focused groups with patients and healthcare professionals, and amended the resource based on their feedback. In this study, investigators will test the HEAL ABC resource and the HEAL ABC intervention for its practicality before further studies will be conducted. HEAL ABC consists of 10 booklets and supportive materials. The order for using the booklets is not specified. Participants will be assigned their first booklet based on the one they perceive to be the easiest for setting an incremental goal and achieving it. This means the participant starts with the booklet of the highest self-efficacy and after the participant achieves successful behaviour change, he or she can move more confidently to the next booklet. During the follow up period, participants will use the follow up booklet which helps them to continue with changes they have made and encourage them to set a new goals. Participants in the intervention group will receive a supportive telephone call every two weeks during the intervention period (three months) and once a month during the six months follow up. Participants allocated to the control group will given information about publicly available resources on healthy lifestyle recommendations. No additional support will be provided. Primary Question/Objective: Is it feasible to run a definitive RCT to determine the effectiveness of HEAL ABC? This study will address questions around suitability and practicality of using the HEAL ABC resource and the ability to run an intervention in relation to adherence, recruitment, retention rates and the ability to collect relevant data. Secondary Question/Objective: Adherence to intervention and the motivations, barriers and facilitators of CRC survivors to follow HEAL ABC.


Recruitment information / eligibility

Status Completed
Enrollment 35
Est. completion date September 30, 2022
Est. primary completion date September 30, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Adults, age =18 - Minimum 12 weeks post-surgery and/or active treatment - Completed all active anti-cancer treatments, including surgery, radiotherapy or chemotherapy - Body mass index =20 kg/m2 and no previous unintentional weight loss =5% of body weight in the previous six months. - Identified as living an unhealthy lifestyle based on current recommendations - follow less than four of the WCRF/AICR recommendations on eligibility questionnaire - Ability to work with computer, smart phone or tablet. - Able to give informed consent. Exclusion Criteria: - Receiving treatment for malignancy. - Secondary malignancy. - Having short bowel syndrome, Crohn's disease, ulcerative colitis, diverticulitis or jejunostomy (due to requirement for a very specific diet). - Previous stroke, congested cardiac failure or oedema. - Hepatic or renal failure - Less than 12 weeks post-surgery or active treatment. - Meeting the requirements of a healthy lifestyle (follow four or more of the WCRF/AICR recommendations). - Being on any therapeutic diets, multiple food intolerances or allergies. - Unplanned weight loss of =10% in the previous 3-6 months. - Cannot read or communicate in English (due to resource constraints of this PhD study).

Study Design


Intervention

Behavioral:
HEAL ABC
Participants will be assigned their first booklet based on the one they perceive to be the easiest for setting an incremental goal and achieving it. After the participant achieves successful behaviour change, he or she can move more confidently to the next booklet. Support will be provided every two weeks over the phone for 12 weeks. During the follow-up period, participants will use the follow-up booklet which helps them to continue with changes they have made and encourage them to set new goals.

Locations

Country Name City State
United Kingdom Manchester University NHS Foundation Trust Manchester
United Kingdom Salford Royal NHS Foundation Trust Manchester Great Manchester
United Kingdom The University of Manchester Manchester

Sponsors (1)

Lead Sponsor Collaborator
University of Manchester

Country where clinical trial is conducted

United Kingdom, 

References & Publications (5)

Aubrey V, Hon Y, Shaw C, Burden S. Healthy eating interventions in adults living with and beyond colorectal cancer: a systematic review. J Hum Nutr Diet. 2019 Aug;32(4):501-511. doi: 10.1111/jhn.12651. Epub 2019 Apr 3. — View Citation

Burden S, Jones DJ, Sremanakova J, Sowerbutts AM, Lal S, Pilling M, Todd C. Dietary interventions for adult cancer survivors. Cochrane Database Syst Rev. 2019 Nov 22;2019(11). doi: 10.1002/14651858.CD011287.pub2. — View Citation

Burden S, Sremanakova J, Jones D, Todd C. Dietary interventions for cancer survivors. Proc Nutr Soc. 2019 Feb;78(1):135-145. doi: 10.1017/S0029665118002690. Epub 2018 Dec 19. — View Citation

Sremanakova J, Jones D, Cooke R, Burden S. Exploring Views of Healthcare Professionals, Researchers, and People Living with and beyond Colorectal Cancer on a Healthy-Eating and Active Lifestyle Resource. Nutrients. 2019 Oct 16;11(10). pii: E2482. doi: 10.3390/nu11102482. — View Citation

Wright SJ, Gibson D, Eden M, Lal S, Todd C, Ness A, Burden S. What are colorectal cancer survivors' preferences for dietary advice? A best-worst discrete choice experiment. J Cancer Surviv. 2017 Dec;11(6):782-790. doi: 10.1007/s11764-017-0615-2. Epub 2017 Apr 20. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Adherence to intervention Assessed as adherence to WCRF/AICR guidelines by using a scoring system for nutrition and physical activity guideline adherence developed by McCullough and colleagues. Number of goals set and number of changes implemented in everyday life during the 3 months intervention. 3 months
Primary Adherence to intervention Assessed as adherence to WCRF/AICR guidelines by using a scoring system for nutrition and physical activity guideline adherence developed by McCullough and colleagues. Number of goals set and number of changes implemented in everyday life during the 6 months follow up. 6 months
Primary Recruitment rates Cumulative recruitment against target rate each month. 3 months
Primary Recruitment rates Cumulative recruitment against target rate each month. 6 months
Primary Retention rates Calculated as the number of participants who completed the study divided by the number of participants randomised. 3 months
Primary Retention rates Calculated as the number of participants who completed the study divided by the number of participants randomised. 6 months
Primary Acceptability of the intervention This will be qualitatively assessed through in depth interviews with a subset of the trial participants. 3 months
Primary Acceptability of the intervention This will be qualitatively assessed through in depth interviews with a subset of the trial participants. 6 months
Primary Data completion rates Completeness of collected data will be assessed for all time points (% missing). 3 months
Primary Data completion rates Completeness of collected data will be assessed for all time points (% missing). 6 months
Secondary Change in participants' experience, motivation, barriers and facilitators to use HEAL ABC resources and follow the intervention Qualitatively assessed with in depth interviews. 3 months and 6 months
Secondary Change in behaviour The health action process approach (HAPA) questionnaires, previously used in publications investigating changes in HAPA constructs in lifestyle interventions. A 5 point Likert scale will be used for each question. Minimum score is 15 and maximum score is 75. Higher score is better score. Baseline, 3 months and 6 months
Secondary Change in dietary intake Three day dietary assessment. Participants will complete prospectively food diary during the day and enter all foods and drinks consumed into online system for dietary assessment - INTAKE24. Baseline, 3 months and 6 months
Secondary Change in BMI Body weight [kg] and height [m] to calculate body mass index Baseline, 3 months and 6 months
Secondary Change in waist to hip ratio waist circumference [cm] and hip circumference [cm] to calculate waist to hip ratio Baseline, 3 months and 6 months
Secondary Change in body composition (BIA) lean mass [%] and fat mass [%] using bio-impedance machine Baseline, 3 months and 6 months
Secondary Change in body composition (CT scan) muscle mass [cm2] and fat mass [cm2]using CT scans body composition analysis Baseline, 3 months and 6 months
Secondary Change in physical activity Global Physical Activity Questionnaire is used to assess the metabolic equivalent (MET) based on Global Physical Activity Questionnaire Analysis Guide: https://www.who.int/ncds/surveillance/steps/resources/GPAQ_Analysis_Guide.pdf Baseline, 3 months and 6 months
Secondary Change in step count pedometer Baseline, 3 months and 6 months
Secondary Patients' socio-demographic characteristics age, gender, marital status, occupation, education, income, ethnicity, smoking status and number of supplements used Baseline
Secondary Contact with primary and secondary healthcare services The Healthcare Resource Use Questionnaire - questionnaire was developed by a health economist for the EU funded project 'PreventIT' (2016-2018, grant number 689238) responding to the Horizon 2020, Personalised Health and Care call PHC-21: Advancing active and healthy aging with ICT: Early risk detection and intervention. There is no set score - questionnaire is used to estimate the costs associated with different healthcare services used. 6 months
Secondary Mortality Patient's medical records 6 months
Secondary Morbidity Patient's medical records 6 months
Secondary Change in Quality of life SF-12 questionnaire - 12 questions, total score can range from 0 to 100 (sore zero indicates the lowest level of health and 100 indicates the highest level of health). Baseline, 3 months and 6 months
See also
  Status Clinical Trial Phase
Recruiting NCT05400122 - Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer Phase 1
Active, not recruiting NCT05551052 - CRC Detection Reliable Assessment With Blood
Completed NCT00098787 - Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer Phase 2
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT05425940 - Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer Phase 3
Suspended NCT04595604 - Long Term Effect of Trimodal Prehabilitation Compared to ERAS in Colorectal Cancer Surgery. N/A
Completed NCT03414125 - Effect of Mailed Invites of Choice of Colonoscopy or FIT vs. Mailed FIT Alone on Colorectal Cancer Screening N/A
Completed NCT02963831 - A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies Phase 1/Phase 2
Recruiting NCT05489211 - Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03) Phase 2
Terminated NCT01847599 - Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib N/A
Completed NCT05799976 - Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure N/A
Recruiting NCT03874026 - Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients Phase 2
Active, not recruiting NCT03170960 - Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors Phase 1/Phase 2
Completed NCT03181334 - The C-SPAN Coalition: Colorectal Cancer Screening and Patient Navigation N/A
Completed NCT03167125 - Participatory Research to Advance Colon Cancer Prevention N/A
Recruiting NCT04258137 - Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study N/A
Recruiting NCT05568420 - A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)
Recruiting NCT02972541 - Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer N/A
Completed NCT02876224 - Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors Phase 1
Completed NCT01943500 - Collection of Blood Specimens for Circulating Tumor Cell Analysis N/A

External Links